VEGF R2/KDR/Flk-1 Antibody (MM0002-2F66) Summary
Immunogen |
This antibody was produced from a hybridoma (mouse myeloma fused withspleen cells from a mouse immunized with human VEGFR2 N-terminal recombinant protein.
|
Marker |
Endothelial Cell Marker
|
Specificity |
VEGFR2. This antibody shows no cross-reactivity with hVEGFR1, hVEGFR3.
|
Isotype |
IgG1
|
Clonality |
Monoclonal
|
Host |
Mouse
|
Gene |
KDR
|
Purity |
Protein G purified
|
Innovators Reward |
Test in a species/application not listed above to receive a full credit towards a future purchase.
Learn about the Innovators Reward
|
Applications/Dilutions
Dilutions |
|
||
Application Notes |
In western blots, this antibody shows no cross-reactivity with hVEGFR1, hVEGFR3.
|
||
Positive Control |
|
Reactivity Notes
Packaging, Storage & Formulations
Storage |
Aliquot and store at -20C or -80C. Avoid freeze-thaw cycles.
|
Buffer |
A 0.2 um filtered solution in PBS
|
Preservative |
No Preservative
|
Concentration |
LYOPH
|
Purity |
Protein G purified
|
Reconstitution Instructions |
Reconstitute with 0.5 ml sterilized PBS to a final concentration of 0.2 mg/ml.
|
Alternate Names for VEGF R2/KDR/Flk-1 Antibody (MM0002-2F66)
- CD309 antigen
- CD309
- EC 2.7.10
- EC 2.7.10.1
- Fetal liver kinase 1
- fetal liver kinase-1
- Flk1
- Flk-1
- FLK1tyrosine kinase growth factor receptor
- KDR
- kinase insert domain receptor (a type III receptor tyrosine kinase)
- Kinase insert domain receptor
- Protein-tyrosine kinase receptor flk-1
- soluble VEGFR2
- vascular endothelial growth factor receptor 2
- VEGF R2
- VEGFR
- VEGFR2
- VEGFR-2